Advocacy intelligence hub — real-time data for patient organizations
Octapharma — PHASE3
Grifols Therapeutics LLC — PHASE3
Monash University — PHASE2, PHASE3
National Institute of Allergy and Infectious Diseases (NIAID)
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all OBSOLETE: Other immunodeficiency syndrome with predominantly antibody defects news →
View all OBSOLETE: Other immunodeficiency syndrome with predominantly antibody defects specialists →